🔬

Audited November 10, 2026

✅Supported

All four claims lack verifiable scientific support. The creator cited 'topical studies,' 'microneedle-patch trial,' and 'multi-peptide serum study' without providing specific study identifiers, authors, or publication details. Searches of PubMed and ClinicalTrials.gov yielded no matching human trials or peer-reviewed publications for any of the specific efficacy claims. While SNAP-8's theoretical mechanism (SNARE inhibition) is scientifically grounded and the peptide is used in cosmetic formulations, the claimed quantitative outcomes (35–60% wrinkle reduction, eye-wrinkle improvement, elasticity gains) and delivery methods (microneedle patch) remain undocumented in human studies. The safety claim similarly lacks formal clinical documentation. Without specific, verifiable citations to actual studies or trials, these claims cannot be assessed against real evidence.

Share this audit

One link — full verdict, every claim, and PubMed citations included.

peptiq.io/check/7e3eca9d…

Shareable link includes the full verdict, claims, and PubMed citations.

Post captionshow

MyPeptideDosages MyPeptideDosages MyPeptideDosages RESEARCH PORTAL MyPeptideDosages Guest User Sign in to unlock all features Sign In NAVIGATION Home Peptide Library Schedule Builder Videos Library Community ACTIONS Create Free Account Sign In Download App SINGLE 10MG SNAP-8 10MG PROTOCOL SNAP-8 10MG INJECTION FREQ. Inject once daily CYCLE SCHED. 8–12 weeks; optional extension to 16 weeks RECON…

Show full post caption

STITUTION 3.0 mL BAC water Reduction in wrinkle depth (average ~35% up to ~60% in certain areas) reported in topical studies Reduced eye-wrinkle appearance and improved skin elasticity in a microneedle-patch trial Smoothing of expression lines reported in a multi-peptide serum study Generally well tolerated no unwanted systemic muscle weakness reported Reconstitution method for SNAP-8 10MG 1 Reconstitution Requirements 3.0 mL BAC water Step Week Range Dose Units 1 Weeks 1–4 330 mcg (0.33 mg) 10 2 Weeks 5–8 500 mcg (0.50 mg) 15 3 Weeks 9–12 1,000 mcg (1.0 mg) 30 4 Weeks 13–16 1,000 mcg (1.0 mg) 30 Inject once daily

Show less

Claim breakdown

4 claims
1

“SNAP-8 causes a reduction in wrinkle depth (average ~35% up to ~60% in certain areas) when applied topically.”

Creator cited:topical studiesStudy doesn't support this
What the study actually says: Creator cited 'topical studies' without naming a specific paper, author, or trial registry ID. No such study could be located in PubMed, ClinicalTrials.gov, or related databases. The citation is vague and unverifiable.
✅Supported

No registered human clinical trials, PubMed publications, or peer-reviewed studies were found documenting topical SNAP-8 efficacy for wrinkle depth reduction at the claimed magnitude (35–60%). The mechanism of SNAP-8 (SNARE-complex inhibition) is theoretically sound for reducing acetylcholine release and muscle contraction, but human efficacy data for topical application with these specific quantitative outcomes does not exist in the scientific literature.

2

“SNAP-8 reduces eye-wrinkle appearance and improves skin elasticity when delivered via a microneedle-patch.”

Creator cited:microneedle-patch trialStudy doesn't support this
What the study actually says: Creator cited 'microneedle-patch trial' without identifying a specific study, trial ID, or publication. No such trial could be located in ClinicalTrials.gov or PubMed. The citation is unspecified and cannot be validated.
✅Supported

No registered human clinical trials or peer-reviewed publications were found for SNAP-8 delivered via microneedle patch for eye-wrinkle reduction or skin elasticity improvement. While microneedle technology is established as a delivery method and SNAP-8's peptide mechanism is documented in preclinical contexts, no human trial data exists for this specific delivery format and outcome claim.

3

“SNAP-8 smooths expression lines when used in a multi-peptide serum.”

Creator cited:multi-peptide serum studyStudy doesn't support this
What the study actually says: Creator cited 'multi-peptide serum study' without specifying authors, journal, trial ID, or publication date. No such study could be located in PubMed or ClinicalTrials.gov. The citation is unverifiable.
❌No Evidence

No registered human clinical trials or peer-reviewed publications were found for SNAP-8 in a multi-peptide serum formulation targeting expression-line smoothing. While multi-peptide cosmetic formulations are common and SNAP-8 is used in topical cosmetics, no clinical trial data exists validating this specific combination or outcome.

4

“SNAP-8 is generally well tolerated with no unwanted systemic muscle weakness reported.”

❌No Evidence

No human clinical trials or peer-reviewed publications were found documenting safety tolerability or absence of systemic muscle weakness for topical SNAP-8. While topical peptides generally do not achieve systemic bioavailability sufficient to cause muscle effects, no formal safety study explicitly addressing this claim in humans exists in the literature.

Audit another post

Instagram, TikTok, X, Reddit, or paste text directly.

New audit

Track your protocols

Dosing, logging, and reminders in the app.

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error